Casi Pharmaceuticals Inc (CASI)
2.31 -0.12 (-4.94%) 12:49 ET [NASDAQ]
2.30 x 9 2.37 x 5
Realtime by (Cboe BZX)
2.30 x 9 2.37 x 5
Realtime - - (-) -
for Wed, Mar 19th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,259 | -40,257 | -35,842 | -47,511 | -45,362 |
| Depreciation Amortization | 3,741 | 2,422 | 1,815 | 1,959 | 2,153 |
| Accounts receivable | 3,422 | -3,170 | -5,158 | -3,352 | -1,293 |
| Accounts payable and accrued liabilities | 1,149 | 1,066 | 1,491 | -1,540 | 4,001 |
| Other Working Capital | -6,830 | -5,461 | -1,938 | -2,046 | 4,452 |
| Other Operating Activity | 4,810 | 24,312 | 12,790 | 26,604 | 12,806 |
| Operating Cash Flow | $-19,967 | $-21,088 | $-26,842 | $-25,886 | $-23,243 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -8,432 | -4,527 | N/A | N/A | -6,626 |
| PPE Investments | -204 | -5,474 | -8,935 | -1,499 | -427 |
| Net Acquisitions | N/A | -2,898 | -86 | -6,401 | -14,038 |
| Sale Of Investment | N/A | 37,622 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -2,037 | N/A | 0 | 2,700 | N/A |
| Other Investing Activity | -1,037 | 6,436 | -11,670 | -12,819 | -6,967 |
| Investing Cash Flow | $-9,673 | $31,159 | $-20,691 | $-20,719 | $-28,058 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 4,001 | 709 | 1,249 | N/A |
| Debt Repayment | N/A | -4,001 | -1,548 | N/A | -1,500 |
| Common Stock Issued | 109 | N/A | 32,500 | 48,973 | 4,311 |
| Common Stock Repurchased | -278 | -3,267 | N/A | N/A | -367 |
| Dividend Paid | -738 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | -2,019 | -3,069 | 19,601 |
| Financing Cash Flow | $-907 | $-3,267 | $29,642 | $47,153 | $22,045 |
| Exchange Rate Effect | 518 | 1,604 | -469 | 2,895 | -1,328 |
| Beginning Cash Position | 47,112 | 38,704 | 57,064 | 53,621 | 84,205 |
| End Cash Position | 17,083 | 47,112 | 38,704 | 57,064 | 53,621 |
| Net Cash Flow | $-30,029 | $8,408 | $-18,360 | $3,443 | $-30,584 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,967 | -21,088 | -26,842 | -25,886 | -23,243 |
| Capital Expenditure | -204 | -5,612 | -8,945 | -1,499 | -427 |
| Free Cash Flow | -20,171 | -26,700 | -35,787 | -27,385 | -23,670 |